ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

Pancreatic Cancer

New Treatment Options and Management Considerations in Borderline Resectable Pancreatic Cancer

In this article we will discuss the definitions of resectability, describe the current diagnostic tests for pancreatic cancer, and review strategies for maximizing treatment outcomes in patients with resectable pancreatic cancer.

Pancreatic Cancer

Germline mutations in pancreatic cancer susceptibility genes were commonly identified in a group of patients with pancreatic cancer who did not report a significant family history of cancer, according to the results of a single-center study.

This video reviews the conflicting data and perspectives regarding the use of radiotherapy in unresectable pancreatic cancer.

This video examines the role of immunotherapy in pancreatic cancer, highlighting the resistance to novel treatments in this setting and trials attempting to confront this problem.

This video examines the management of resectable pancreatic cancer, including how this type of disease is best defined, the latest standard of care in the adjuvant setting, and emerging trends in surveillance.

Adding PEGPH20 to nab-paclitaxel and gemcitabine improved progression-free survival in patients with untreated, metastatic pancreatic ductal adenocarcinoma.

In this article we will discuss the definitions of resectability, describe the current diagnostic tests for pancreatic cancer, and review strategies for maximizing treatment outcomes in patients with resectable pancreatic cancer.

This video highlights the evolution of stereotactic body radiation therapy in the treatment of pancreatic cancer.

Pages

Subscribe to Pancreatic Cancer on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.